EYEN Eyenovia Corp: Earnings growth forecast for next year

Corporate company logo of Eyenovia Corp (EYEN)

The target EPS growth rate for next year in the consolidated chart on GURU.Markets contains the current metric level 0.00 for Eyenovia, Inc. (EYEN). Strict patents on inkjet delivery and FDA regulations serve as a moat for the business. The team brings together biologists and engineers attracted by stock options and a lack of bureaucracy. Prospects depend on the commercial success of Optejet and the results of pediatric myopia therapy.

EYEN - Eyenovia Inc. Expected net earnings per share growth next year over the range 07/04/2022 - 07/03/2025

Analytical breakdowns for Eyenovia Corp (EYEN)

- price and consensus price forecast:
Fundamental company analysis:Eyenovia
Core merchandise of Eyenovia Inc.

For Eyenovia, Inc. (EYEN), whose success depends on the qualifications of ophthalmologists and the progress of microdosing clinical trials, the trend of consensus EPS forecasts for the coming year serves as a leading indicator of market expectations. This metric measures the percentage change in expected earnings per share, reflecting the speed at which analysts revise the business's fundamental value, allowing investors to assess risk or capital growth potential prior to the publication of official reports.

Key competitors

ALC (Alcon Corp) - Earnings growth forecast for next year|Bausch + Lomb Corporation (BLCO) - Consensus forecast of earnings per share growth for next year|Earnings growth forecast for next year GKOS|Earnings growth forecast for next year Apellis Pharmaceuticals, Inc. (APLS)|Earnings growth forecast for next year BLTE (Belite Bio)|OCUL - Expected earnings per share growth for next year|HROW - Net earnings per share growth forecast for next year|Expected earnings per share trend next year VRDN (Viridian Therapeutics)|LENZ (LENZ Therapeutics, Inc.) - Expected earnings per share growth for next year|Oculis Holding AG - Expected earnings per share trend next year|Net earnings per share growth forecast for next year eyepointpharma.com|Earnings growth forecast for next year Kodiak Sciences Inc.|Net earnings per share growth forecast for next year Aldeyra Therapeutics Inc. (ALDX)|Net earnings per share growth forecast for next year KALA (KALA BIO)|Net earnings per share growth forecast for next year opusgtx.com IRD|Expected earnings per share trend next year OKYO|ADVM: Expected earnings per share growth for next year|Expected earnings per share trend next year OTLK (Outlook Therapeutics)|CLSD: Earnings growth forecast for next year|NovaBay Pharmaceuticals Inc. - Expected earnings per share trend next year|Net earnings per share growth forecast for next year kiorapharma.com|Expected earnings per share growth for next year Alimera Sciences (ALIM)|Earnings growth forecast for next year GHSI|OCUP (Ocuphire) - Expected earnings per share trend next year|Earnings growth forecast for next year OPT (Opthea Ltd)